the consequences of abortion in women with intrauterine fetal death. Medical abortion : complete or unspecified, without complication
Conditions
Interventions
Intervention 1: The recommended dose of misogyny with FIGO protocol for termination of pregnancy due to intrauterine fetal death is 200 µg vaginal every four hours for a maximum of five doses. For the
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Iranian nationality Married Older and equal to 18 years Gestational age 12 to 20 weeks Having a single fetus according to ultrasound confirmation Initial bishop score less than four BMI less than 30 Indication of termination of pregnancy due to intrauterine death of the fetus with confirmation two ultrasounds
Exclusion criteria
Exclusion criteria: Drugs abuse smoking more than ten cigarettes a day History of cesarean section Contraindications to the use of evening primrose include: history of mental illness with phenothiazine, history of epilepsy, schizophrenia, history of bleeding disorders and use of anticoagulants Medical disorders in the mother such as heart disease, lung disease, active liver disease, acute hepatitis Previously known drug allergies to misoprostol include drowsiness, tremors, seizures, shortness of breath, hypotension, and bradycardia (WWW.Drugs.com) Medicinal allergies to evening primrose, including urticaria, wheezing, facial edema, lips, tongue and throat (WWW.Drugs.com) Severe anemia Having cervical anomalies Evening capsule vaginal capsule for two weeks continuous Severe vaginal bleeding Enema Having a history of unsuccessful pregnancy History of using any herbal and chemical drugs to help abortion before admission Contraindications to misoprostol use include: ectopic pregnancy, use of estrodiol-free drugs, symptoms of pelvic infection or sepsis, unstable hemodynamic status, mitral stenosis, glaucoma, asthma, bronchitis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean duration from the beginning of the intervention to embryo expulsion. Timepoint: Beginning of the intervention to embryo expulsion. Method of measurement: Minute. | — |
Secondary
| Measure | Time frame |
|---|---|
| The mean dose of misoprostol. Timepoint: End of intervention. Method of measurement: Microgram.;Intensity of pain. Timepoint: End of intervention. Method of measurement: Visual Analogue Scale-VAS.;People in need of blood transfusions. Timepoint: Blood transfusion time. Method of measurement: Frequency.;People in need of curettage. Timepoint: End of intervention. Method of measurement: Frequency.;Side effects of medications (fever, nausea, vomiting, diarrhea, chills). Timepoint: From the beginning of the intervention until one hour after the fetus is expelled. Method of measurement: Frequency. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMasoumeh Farahani
Karaj University of Medical Sciences
Outcome results
None listed